2005
DOI: 10.1373/clinchem.2004.047126
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Two Common Polymorphisms in the ATP Binding Cassette Transporter A1 Gene on HDL-Cholesterol Concentration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
9
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 18 publications
2
9
0
Order By: Relevance
“…Some of the earlier reports are consistent with our results (Woll et al 2005;Pasdar et al 2007;Frikke-Schmidt et al 2008), however, some studies have shown different results (Yamakawa-Kobayashi et al 2003;Porchay et al 2006;Benton et al 2007;Miller et al 2007). Nevertheless, we could not find any correlation between R219K polymorphism and lipid profile except in elevated ApoA1 levels.…”
Section: Discussionsupporting
confidence: 93%
“…Some of the earlier reports are consistent with our results (Woll et al 2005;Pasdar et al 2007;Frikke-Schmidt et al 2008), however, some studies have shown different results (Yamakawa-Kobayashi et al 2003;Porchay et al 2006;Benton et al 2007;Miller et al 2007). Nevertheless, we could not find any correlation between R219K polymorphism and lipid profile except in elevated ApoA1 levels.…”
Section: Discussionsupporting
confidence: 93%
“…It has been well documented that polymorphisms in these genes are associated with changes in HDL-C concentrations (911, 13, 14, 19, 22). The differences in HDL-C concentrations associated with these polymorphisms, however, are not reliable predictors of their potential cardiovascular benefit (9, 10, 19, 24). In the current study, we measured lipoprotein subclasses by NMR to determine whether additional information gained from such measurement yields insights not provided by conventional lipoprotein measurements.…”
Section: Discussionmentioning
confidence: 99%
“…The ABCA1 1051G/A (rs#2230806) and −565C/T (previously designated as −477) (rs#2422493) polymorphisms were genotyped as described by Woll et al (10) and CETP TaqIB (rs#708272), −2505C/A, −629C/A (rs#1800775), R451Q (rs#1800777), and A373P (rs#5880) polymorphisms as described (1518). …”
Section: Methodsmentioning
confidence: 99%
“…The SNPs used were rs2230806 (also designated as rs2234884) which encodes variant R219K (c.969A>G, numbering according to GenBank reference NM_005502) with a reported ~25% minor allele frequency in Caucasian populations [5,7]; rs2066718 which is a V771M (c. 2624A>G) variant with a reported~3% minor allele frequency [5,7]; rs2230808 which encodes a R1587K (c.5073A>G) variant with a reported 26% minor allele frequency [5,7], and finally rs2422493 which is a 5−UTR polymorphism located at −477 in the promoter with a reported 46% minor allele frequency [23,25]. Subsequent to us choosing these SNPs, rs2230808 and rs2066718 variants were reported to be associated with variability in plasma HDL levels [7][8][9] and with plasma cholesterol levels; which further validated their use in this association study.…”
Section: Methodsmentioning
confidence: 99%